General
COVID lives updates: South Korea resumes use of AstraZeneca vaccine for people under 60 after blood clot concerns
South Korea resumes use of AstraZeneca vaccine
South Korea says it will resume administrating AstraZeneca’s COVID-19 vaccine to all eligible people between the ages of 30 and 60.
Last week, it suspended the use of the vaccine for people under 60 while awaiting the outcome of the European Medicine Agency’s review.
The EMA said it had found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults (you can read more on that here).
The Korea Disease Control and Prevention Agency now says it will restart the use of AstraZeneca vaccine beginning Monday, citing studies showing that the vaccine’s benefits outweighs the risk of side effects.
An agency statement said people under 30 will be…
-
General13 hours agoShark attack at Tathra Beach leaves 9yo surfer’s board in pieces
-
Noosa News14 hours agoUnborn baby boy fighting for life after 38-week pregnant woman and partner hit by racing P-platers on the Gold Coast
-
Noosa News14 hours agoTruck driver dies after vehicle smashes into Queensland retirement home
-
General21 hours agoCoroner recommends prison communication review after Lathan Brown’s death